STOCK TITAN

Becton Dickinson (BDX) director acquires 272 deferred stock rights in plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Becton, Dickinson and Company director Christopher Ian Montague Jones acquired additional deferred stock rights under the BD Deferred Compensation Plan. On February 4, 2026, he acquired 272 rights to common stock at a reference price of $201.91 per right. Each right converts into one share of BD common stock. Following this transaction, he beneficially owns 11,649 derivative securities representing rights to BD common stock, held directly. These securities are scheduled to be distributed after his service as a director ends, or on dates he has previously specified, and the total includes rights accumulated through dividend reinvestment.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jones Christopher Ian Montague

(Last) (First) (Middle)
C/O BECTON, DICKINSON AND COMPANY
1 BECTON DRIVE

(Street)
FRANKLIN LAKES NJ 07417

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BECTON DICKINSON & CO [ BDX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Rights to Common Stock Under BD Deferred Compensation Plan (1) 02/04/2026 A 272 (2) (2) Common Stock 272 $201.91 11,649(3) D
Explanation of Responses:
1. The securities convert to common stock on a one-for-one basis.
2. The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.
3. Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.
Remarks:
Donna Kalazdy, by power of attorney from Christopher Jones 02/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Becton Dickinson (BDX) director Christopher Jones report?

Christopher Ian Montague Jones reported acquiring 272 rights to Becton Dickinson common stock under the BD Deferred Compensation Plan at a reference price of $201.91 per right. The transaction occurred on February 4, 2026, and is coded as an acquisition of derivative securities.

How many deferred stock rights does Becton Dickinson (BDX) director Christopher Jones now hold?

After the February 4, 2026 transaction, Christopher Ian Montague Jones beneficially owns 11,649 derivative securities, consisting of rights to Becton Dickinson common stock under the BD Deferred Compensation Plan. This figure also includes rights accumulated through dividend reinvestment since his last reported filing.

What do the rights to common stock under Becton Dickinson’s deferred compensation plan represent?

The reported rights under Becton Dickinson’s deferred compensation plan convert into common stock on a one-for-one basis. Each right corresponds to a single share of BD common stock, providing the director with future stock distribution rather than immediate share ownership at the time of accrual.

When will Becton Dickinson (BDX) director Christopher Jones receive the shares from these deferred rights?

The deferred rights are distributed after Christopher Ian Montague Jones’s service as a director terminates, or on the specific date or dates he has previously selected. Until distribution, they remain as derivative rights rather than outstanding common shares directly held.

How were additional rights accumulated in Becton Dickinson (BDX) director Christopher Jones’s deferred account?

The total reported rights for Christopher Ian Montague Jones include units acquired through dividend reinvestment. When Becton Dickinson pays dividends, the value can be reinvested to purchase additional deferred stock rights, which are then added to his existing balance under the plan.

Is the Becton Dickinson (BDX) insider holding these deferred rights directly or indirectly?

The filing shows that Christopher Ian Montague Jones holds 11,649 derivative securities representing rights to Becton Dickinson common stock as a direct ownership position. No indirect ownership entity or special nature of indirect beneficial ownership is indicated for this transaction.
Becton Dickinson & Co

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Latest SEC Filings

BDX Stock Data

58.84B
283.77M
0.57%
92.26%
1.59%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
FRANKLIN LAKES